Paul Edwards joins Graffinity Pharmaceuticals of Heidelberg, Germany, as associate director of medicinal chemistry, the company said last week. Edwards, 35, will report to Achim Feurer, director of medicinal chemistry, who in turn reports to Victor Matassa, vice president, research and development. Edwards previously was principal scientist at Pfizer Global Research and Development. He holds a PhD in organic chemistry from the University of Leicester. Graffinity uses a chemical drug-fragment microarray platform for its efforts in drug discovery and pre-clinical development.
Ramesh Hariharan, chief technology officer of Strand Genomics, was one of 20 Indus Technovators award winners presented to innovators of Indian origin by the Indian Business Club of the Sloan School of Business at Massachusetts Institute of Technology.
Joseph Puglisi, associate professor of structural biology at the Stanford University School of Medicine and director of the Stanford Magnetic Resonance Laboratory, has joined the scientific advisory board of PTC Therapeutics of South Plainfield, NJ. Puglisi’s research interest is the role of RNA in cellular processes and disease.
Daniel Chagnovich joins Velcura Therapeutics of Ann Arbor, Mich., as senior scientist in bioinformatics. Previously, he was a scientist in the molecular technologies group of Pfizer’s Global Research and Development Center. He holds a PhD from Northwestern University Medical School in Chicago where he studied the control of gene expression in human neuroblastomas.
Mina Bissell, director of the life sciences division at Lawrence Berkeley National Laboratory has been named the 2003 winner of the Brinker Award for Scientific Distinction in Research. The award, which includes a $10,000 honorarium, is sponsored by the Susan G. Komen Breast Cancer Foundation. Bissell is investigating the network of physical and biochemical signals that converge in an orchestrated manner to effect signaling that governs gene expression within bodily tissues.